Soley Therapeutics

About:

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.

Website: https://soleytherapeutics.com

Description:

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs, using image acquisition-based approaches. Soley Therapeutics has taken an orthogonal approach to discover new drugs by developing a technology platform to measure how cells respond multi-dimensionally in response to drugs. We have developed a novel platform for high-content phenotypic drug screening, where the drug effect on a cell can be visualized via molecular-microscopic images and analyzed by using sophisticated AI tools.

Total Funding Amount:

$20M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2018-01-01

Founders:

Kurosh Ameri, Yerem Yeghiazarians

Number of Employees:

11-50

Last Funding Date:

2020-12-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai